Rajeev A. Modi - Mar 1, 2024 Form 4 Insider Report for Elanco Animal Health Inc (ELAN)

Role
Executive Vice President U.S. Pet Health and Global Digital Transformation
Signature
/s/ Amy C. Seidel, as Attorney-in-Fact for Rajeev A. Modi
Stock symbol
ELAN
Transactions as of
Mar 1, 2024
Transactions value $
-$57,964
Form type
4
Date filed
3/5/2024, 04:27 PM
Previous filing
Feb 27, 2024
Next filing
Mar 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ELAN Common Stock Award $0 +19.7K +32.09% $0.00 80.9K Mar 1, 2024 Direct F1, F2
transaction ELAN Common Stock Tax liability -$58K -3.62K -4.47% $16.03 77.3K Mar 1, 2024 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELAN Employee Stock Option(right to buy) Award $0 +42.9K $0.00 42.9K Mar 1, 2024 Common Stock 42.9K $16.03 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Grant of restricted stock units pursuant to the Amended and Restated 2018 Elanco Stock Plan on March 1, 2024, one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.
F2 Includes 1,588 shares acquired on June 30, 2023, and 802 shares acquired on September 29, 2023, under Elanco Animal Health Inc.'s Employee Stock Purchase Plan .
F3 Represents shares tendered to the Company to cover the Reporting Person's tax liability upon vesting of restricted stock units previously awarded under the Amended and Restated 2018 Elanco Stock Plan.
F4 Grant of stock options vesting as follows: one-third vesting on March 1, 2025, one-third vesting on March 1, 2026, and the remaining vesting on March 1, 2027.

Remarks:

Executive Vice President U.S. Pet Health and Global Digital Transformation